VR Gaming Based PNF on Spatiotemporal Parameters in Upper Limb Burned Patients

January 9, 2026 updated by: Ahmed Mohamed Ahmed Abd El hady El Fahl,ph.d, MTI University

Visual Reality Gaming Based Proprioceptive Neuromuscular Facilitation on Spatiotemporal Parameters in Upper Limb Burned Patients

Burn injuries are among the most severe forms of trauma, often leading to significant physical and psychological challenges. The rehabilitation process for burn patients, particularly those with upper limb injuries, is complex due to the need for restoring functional movement and reducing scar contracture. Traditional rehabilitation methods focus on restoring range of motion, muscle strength, and coordination. However, these approaches can be limited in engaging patients and maintaining their motivation throughout the recovery process.

Study Overview

Detailed Description

Upper limb burn injury (ULBI) often leads to significant dysfunction . Severe pain, limited range of motion in the joint and kinesiophobia may affect upper limb functionality and activities of daily living in the acute term of injury . Increased pain and limitations in range of motion and function of the upper limb may cause deterioration in reciprocal arm swing which plays a substantial role in gait pattern by contributing to the co-ordination of the trunk, pelvis and leg movements, reducing energy expenditure and improving gait stability and balance.

Proprioceptive Neuromuscular Facilitation (PNF) is a therapeutic exercise technique used to enhance both passive and active range of motion with the aim of improving neuromuscular control and coordination. By integrating PNF with innovative technologies such as Virtual Reality (VR) gaming systems, rehabilitation can be transformed into an engaging and immersive experience. VR provides a unique environment that can simulate real-life scenarios, offering a controlled yet dynamic setting that encourages active participation and motivation.

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11311
        • Faculty of Physical Therapy ,Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Clinical diagnosis of unilateral upper extremity burn injury
  • must be able to walk independently
  • Agreeing to participate voluntarily in the study
  • 18-65 years of age
  • the ability to accurately express the level of pain that prevents cognitive, affective and verbal communication

Exclusion Criteria:

  • Walking with assist device
  • Having a visual deficits
  • Having an orthopedic problems that affect gait
  • Having a neurological disorders
  • Having a musculoskeletal disorders that affect gait
  • Having an undergone orthopedic surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
No intervention
Experimental: Proprioceptive neuromuscular facilitation (PNF)
In the PNF group, The PNF sequence included scapula, upper limb, Training was performed in different positions
Training was performed in different positions (decubitus, sitting, and standing) according to the specific exercise. the participants performed 10 minutes of diagonal scapula exercises (anterior and posterior elevation) and 30 minutes of upper limb diagonals (Flexion-Abduction-External Rotation and Extension-Abduction-Internal Rotation), including the 5 initial minutes of stretching.
Experimental: Visual reality (VR)
In the VR group, the tasks were performed with the aid of a Nintendo Wii device.
The site of the intervention was a 20-square-meter room equipped with a multimedia projector, which projected the image on the wall at a height of 1 m and 20 cm. A professional physical therapist supervised the treatment continuously, and every participant received prior instructions on the conduct of the games. The therapeutic protocol included 4 electronic games: Balance Bubble Plus, Rhythm Parade, Tennis, and Box.
Experimental: PNF and VR
The PNF/VR group performed both PNF and VR exercises. The duration of the exercises was modified so that half of the time was devoted to PNF and the other half to VR
The total duration of the sessions remained consistent. The participants performed 5 minutes of scapula diagonals and 15 minutes of upper limb diagonals in the weekly session. The games for the PNF/VR group were the same as those for the VR group, except for their duration. Whereas they were performed for 20 minutes each in the VR group, the session including 5 minutes of stretching.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kinesiophobia
Time Frame: at baseline and at 12 weeks
the Arabic version of the Tampa Scale for Kinesiophobia (TSK) was used. The TSK is rated on a 4-point Likert scale ranging from 17 to 68, with higher scores indicating a high level of kinesiophobia . The TSK has been shown to be a reliable tool for the measurement of kinesiophobia in patients with (upper limb burn injury) ULBI.
at baseline and at 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait Analysis
Time Frame: at baseline and at 12 weeks
The GAITRite (CIR System INC. Clifton, NJ, USA, 07012) electronic walkway was used to evaluate the spatio-temporal parameters during walking. Participants walked barefoot at self-selected pace. Gait analysis was started after a trial to allow the participants to become familiar with the test. Gait velocity, cadence and bilateral gait parameters of step length, stride length, percentage of stance and swing were used for analysis. In addition spatio-temporal parameters and plantar pressure distribution were analyzed during walking. The GAITRite system expresses the plantar pressure value as a percentage of the maximum pressure.
at baseline and at 12 weeks
Arm swing
Time Frame: at baseline and at 12 weeks
The arm swing movements during walking were evaluated with free version of Kinovea 2D motion analysis software (Kinovea 0.8.15., GPLv2 license, 2019). It is a reliable method to analyze the upper extremity movements and gait analysis . For tracking the segments of the upper limbs during walking, sticker markers were placed in specific anatomical areas (left/right acromions, left/right medial and lateral epicondyles, and left/right distal radius and ulna landmarks) . The shoulder, elbow, and wrist joints were manually positioned within the Kinovea software to accurately map the participants' upper body movements. Based on the identified joint centers, the upper arm, lower arm, and full arm segments were determined. Detailed analyses were conducted to evaluate the shoulder angle (measured from the shoulder joint marker to the elbow joint marker), the elbow angle (measured from the elbow joint marker to the midpoint of the wrist joint marker).
at baseline and at 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2025

Primary Completion (Actual)

January 1, 2026

Study Completion (Actual)

January 5, 2026

Study Registration Dates

First Submitted

September 8, 2025

First Submitted That Met QC Criteria

September 13, 2025

First Posted (Estimated)

September 19, 2025

Study Record Updates

Last Update Posted (Actual)

January 13, 2026

Last Update Submitted That Met QC Criteria

January 9, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burns

Clinical Trials on Proprioceptive neuromuscular facilitation (PNF)

3
Subscribe